“Analgesic effect of intravenous versus intraperitoneal dexmedetomidine as an adjuvant to intraperitoneal bupivacaine (0.125%) in laparoscopic cholecystectomy: a randomized, double blind, interventional study ”, J. Appl. Pharm. Res., vol. 10, no. 3, pp. 12-17, Sep. 2022.